Belhadj Salem, L., Bosquillon, C., Dailey, L. A., Delattre, L., Martin, G. P., Evrard, B., & Forbes, B. (2009). Sparing methylation of β-cyclodextrin mitigates cytotoxicity and permeability induction in respiratory epithelial cell layers in vitro. Journal of Controlled Release, 136, 110-116. doi:10.1016/j.jconrel.2009.01.019 Peer Reviewed verified by ORBi |
Castagne, D., Fillet, M., Delattre, L., Evrard, B., Nusgens, B., & Piel, G. (2009). Study of the cholesterol extraction capacity of β-cyclodextrin and its derivatives, relationships with their effects on endothelial cell viability and on membrane models. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 63 (3-4), 225-231. doi:10.1007/s10847-008-9510-9 Peer reviewed |
Noël, A., Herman, L., Hubert, P., Delvenne, P., Boniver, J., Evrard, B., Delattre, L., Frankenne, F., & Foidart, J.-M. (27 November 2008). MUCOADHESIVE PHARMACEUTICAL COMPOSITIONS COMPRISING CHEMOATTRACTANTS. |
Defrère, S., Squifflet, J., Lousse, J. C., Van Langendonck, A., Gonzalez-Ramos, R., Foidart, J.-M., Jérôme, C., Delattre, L., Donnez, J., & Dehoux, J. P. (April 2008). Unsuccessful Induction of Endometriosis in Female Rhesus Macaques (Macaca mulatta). Gynecologic and Obstetric Investigation, 66 (2), 84-90. doi:10.1159/000127447 Peer Reviewed verified by ORBi |
Barillaro, V., Dive, G., Ziemons, E., Bertholet, P., Evrard, B., Delattre, L., & Piel, G. (10 February 2008). Theoretical and Experimental Vibrational Study of Miconazole and Its Dimers with Organic Acids: Application to the IR Characterization of Its Inclusion Complexes with Cyclodextrins. International Journal of Pharmaceutics, 350 (1-2), 155-165. doi:10.1016/j.ijpharm.2007.08.048 Peer Reviewed verified by ORBi |
Barillaro, V., Dive, G., Bertholet, P., Evrard, B., Delattre, L., Frederich, M., Ziemons, E., & Piel, G. (22 January 2008). Theoretical and Experimental Investigations of Organic Acids/Cyclodextrin Complexes and Their Consequences Upon the Formation of Miconazole/Cyclodextrin/Acid Ternary Inclusion Complexes. International Journal of Pharmaceutics, 347 (1-2), 62-70. doi:10.1016/j.ijpharm.2007.06.030 Peer Reviewed verified by ORBi |
Castagne, D., Fillet, M., Delattre, L., Evrard, B., Nusgens, B., & Piel, G. (November 2007). Interaction de la b-cyclodextrine et de ses dérivés avec des cellules endothéliales: dosage du cholestérol résiduel [Paper presentation]. 10èmes Journées du Club français des Cyclodextrines, Lens, France. |
Bodson, C., Rozet, E., Ziemons, E., Evrard, B., Hubert, P., & Delattre, L. (18 October 2007). Validation of manufacturing process of Diltiazem HCl tablets by NIR spectrophotometry (NIRS). Journal of Pharmaceutical and Biomedical Analysis, 45 (2), 356-361. doi:10.1016/j.jpba.2007.05.015 Peer Reviewed verified by ORBi |
Piel, G., Ducat, E., Grammenos, A., Evrard, B., & Delattre, L. (October 2007). Encapsulation of betamethasone-HP-gCD complex in deformable liposomes [Poster presentation]. 1st conference on "innovation in drug delivery: from biomaterials to devices", Naples, Italy. |
Castagne, D., Delattre, L., Evrard, B., Fillet, M., Nusgens, B., & Piel, G. (October 2007). Cell membrane destructuration using cyclodextrins: effect on cholesterol content of endothelial cells [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
Dehousse, V., Piel, G., Delattre, L., & Evrard, B. (October 2007). Characterization of siRNA lipoplexes in terms of size and zeta potential data [Poster presentation]. 1st conference on "innovation in drug delivery: from biomaterials to devices", Naples, Italy. |
Krell, H.-W., Cataldo, D., Delattre, L., Evrard, B., & Foidart, J.-M. (27 September 2007). USE OF A TRIOXOPYRIMIDINE FOR THE TREATMENT AND PREVENTION OF BRONCHIAL INFLAMMATORY DISEASES. |
Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (29 June 2007). Study of the relationship between lipid binding properties of cyclodextrins and their effect on the integrity of liposomes. International Journal of Pharmaceutics, 338 (1-2), 35-42. doi:10.1016/j.ijpharm.2007.01.015 Peer Reviewed verified by ORBi |
Tursilli, R., Piel, G., Delattre, L., & Scalia, S. (June 2007). Solid lipid microparticles containing the sunscreen agent, octyl-dimethylaminobenzoate: Effect of the vehicle. European Journal of Pharmaceutics and Biopharmaceutics, 66 (3), 483-487. doi:10.1016/j.ejpb.2007.02.017 Peer Reviewed verified by ORBi |
Castagne, D., Belhadj Salem, L., Delattre, L., Nusgens, B., & Piel, G. (April 2007). Evaluation of the cytotoxicity of cyclodextrins on endothelial cells using MTT assay [Poster presentation]. Pharmaceutical Sciences World Congress, Amsterdam, Netherlands. |
Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (April 2007). Study of the interaction between cyclodextrins and liposome membranes: effect on the permeability of liposomes. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 57 (1-4), 309-311. doi:10.1007/s10847-006-9178-y Peer reviewed |
Piette, M., Castagne, D., Delattre, L., & Piel, G. (April 2007). Preparation and evaluation of liposomes encapsulating synthetic MMP inhibitor (Ro 28-2653) - cyclodextrin complexes. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 57 (1-4), 101-103. doi:10.1007/s10847-006-9214-y Peer reviewed |
Ziemons, E., Dive, G., Debrus, B., Barillaro, V., Frederich, M., Lejeune, R., Angenot, L., Delattre, L., Thunus, L., & Hubert, P. (February 2007). Study of the physicochemical properties in aqueous medium and molecular modeling of tagitinin C/cyclodextrin complexes. Journal of Pharmaceutical and Biomedical Analysis, 43 (3), 910-919. doi:10.1016/j.jpba.2006.09.011 Peer Reviewed verified by ORBi |
Brion, M., Nizet, D., Piel, G., Delattre, L., & Evrard, B. (2007). Optimisation de la réaction de complexation entre une cyclodextrine et un composé pharmaceutique par utilisation du CO2 supercritque [Paper presentation]. 10èmes Journées du Club français des Cyclodextrines, Lens, France. |
Jaspart, S., Bertholet, P., Piel, G., Dogné, J.-M., Delattre, L., & Evrard, B. (January 2007). Solid lipid microparticles as a sustained release system for pulmonary drug delivery. European Journal of Pharmaceutics and Biopharmaceutics, 65 (1), 47-56. doi:10.1016/j.ejpb.2006.07.006 Peer Reviewed verified by ORBi |
Nizet, D., Zalfen, A., Collard, L., Krier, F., Jérôme, C., Frankenne, F., Delattre, L., & Evrard, B. (2007). Development of an original intra-uterine implant allowed specific release kinetics of several drugs [Poster presentation]. Innovation in drug delivery: from biomaterials to devices, Naples, Italy. |
Krier, F., Nizet, D., Riva, R., colombo, M., Frankenne, F., Jérôme, C., Piel, G., Delattre, L., & Evrard, B. (2007). DEVELOPMENT OF AN INTRAPERITONEAL IMPLANT FOR THE ENDOMETRIOSIS TREATMENT [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
Brion, M., Nizet, D., Piel, G., Delattre, L., & Evrard, B. (2007). Optimization of drug-cyclodextrin complexation reaction by a static supercritical carbon dioxide method [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
Belhadj Salem, L., Bosquillon, C., Delattre, L., Martin, G., Evrard, B., & Forbes, B. (2007). Kleptose Crysmeb is a biocompatiblecyclodextrin solubiliser for pulmonary delivery of Ro 28-2653, a new synthetix matrix metalloproteinase inhibitor [Poster presentation]. Pharmaceutical Sciences World Congress. |
Belhadj-Salem, L., Bosquillon, C., Delattre, L., Martin, G., Forbes, B., & Evrard, B. (2007). Effect of cyclodextrin derivatives on bronchial epithelial cell layer permeability [Poster presentation]. Innovation in drug delivery: from biomaterials to devices, Naples, Italy. |
Nizet, D., Jaspart, S., Brion, M., Piel, G., Delattre, L., & Evrard, B. (2007). Supercritical fluid technology to produce solid lipid microparticles [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
Dehousse, V., Piel, G., Delattre, L., & Evrard, B. (2007). Studies on the structure of cationic liposomes/siRNA complexes by zeta potential and size measurement [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
Nizet, D., Zalfen, A., Collard, L., Krier, F., Jérôme, C., Frankenne, F., Maquet, V., Delattre, L., & Evrard, B. (2007). Controlled release of drugs from an original multi-component device [Poster presentation]. Biomedica 2007, aachen, Germany. |
Evrard, B., Bertholet, P., Guéders, M., Piette, M., Piel, G., Cataldo, D., & Delattre, L. (2007). Contribution of cyclodextrins in the developement of different pharmaceutical formulations of a nex matrix metalloproteinase inhibitor. Journal of Inclusion Phenomena and Molecular Recognition in Chemistry, 57 (1-4), 303-308. doi:10.1007/s10847-006-9177-z Peer Reviewed verified by ORBi |
Jaspart, S., Delattre, L., & Evrard, B. (2007). Formulation and in vitro evaluation of inhalable dry powders containing solid lipid nanoparticles [Poster presentation]. Innovation in drug delivery: from biomaterials to devices, Naples, Italy. |
Nizet, D., Zalfen, A., Jérôme, C., Frankenne, F., Delattre, L., & Evrard, B. (2007). Controlled release of drug from multicomponent device [Poster presentation]. Pharmaceutical Sciences World Congress, Amsterdam, Netherlands. |
Barillaro, V., Dive, G., Bertholet, P., Evrard, B., Delattre, L., Ziemons, E., & Piel, G. (2007). Theoretical and experimental investigations on miconazole/cyclodextrin/acid complexes: Molecular modeling studies. International Journal of Pharmaceutics, 342 (1-2), 152-160. doi:10.1016/j.ijpharm.2007.05.003 Peer Reviewed verified by ORBi |
Castagne, D., Belhadj Salem, L., Delattre, L., Nusgens, B., & Piel, G. (2007). Effect of cyclodextrins on the viability of endothelial cells. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 57 (1-4), 105-107. doi:10.1007/s10847-006-9211-1 Peer reviewed |
Hubert, P., Evrard, B., Delattre, L., Boniver, J., Delvenne, P., Noël, A., Frankenne, F., & Foidart, J.-M. (12 December 2006). Mucoadhesive composition comprising polyacrylate and chemoattractant. |
Piel, G., Coia, I., Uhoda, E., Pierard, G., Evrard, B., & Delattre, L. (October 2006). Assessment of betamethasone-in-cyclodextrin-in-liposome induced skin blanching response [Poster presentation]. Skin and Formulation, 2nd Symposium, Versailles, France. |
Lumay, G., Vandewalle, N., Delattre, L., Gerasimov, O., & Bodson, C. (28 August 2006). Linking compaction dynamics to the flow properties of powders. Applied Physics Letters, 89 (9). doi:10.1063/1.2338801 Peer Reviewed verified by ORBi |
Herman, L., Hubert, P., Delvenne, P., Boniver, J., Evrard, B., Delattre, L., Frankenne, F., Noël, A., & Foidart, J.-M. (28 June 2006). MUCOADHESIVE PHARMACEUTICAL COMPOSITIONS COMPRISING CHEMOATTRACTANTS. |
Bodson, C., Dewé, W., Hubert, P., & Delattre, L. (07 June 2006). Comparison of FT-NIR transmission and UV-vis spectrophotometry to follow the mixing kinetics and to assay low-dose tablets containing riboflavin. Journal of Pharmaceutical and Biomedical Analysis, 41 (3), 783-790. doi:10.1016/j.jpba.2006.01.022 Peer Reviewed verified by ORBi |
Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (June 2006). Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions. European Journal of Pharmaceutical Sciences, 28 (3), 189-195. doi:10.1016/j.ejps.2006.01.011 Peer Reviewed verified by ORBi |
Piette, M., Castagne, D., Delattre, L., & Piel, G. (May 2006). Preparation and evaluation of liposomes encapsulating synthetic MMP inhibitor (Ro 28-2653) - cyclodextrin complexes [Poster presentation]. 13th International Cyclodextrin Symposium, Turin, Italy. |
Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (07 April 2006). Betamethasone-in-cyclodextrin-in-liposome: The effect of cyclodextrins on encapsulation efficiency and release kinetics. International Journal of Pharmaceutics, 312 (1-2), 75-82. doi:10.1016/j.ijpharm.2005.12.044 Peer Reviewed verified by ORBi |
Bosquillon, C, Belhadj Salem, L, Hernandez, E, Martin, G.P, Delattre, L., Evrard, B., & Forbes, B. (2006). Effect of ß-Cyclodextrin Derivatives on Bronchial Epithelial Cell Layer Permeability. Delivery to the lung, 17, 90-93. Peer reviewed |
Zalfen, A., Nizet, D., Jérôme, C., Delattre, L., Frankenne, F., & Evrard, B. (2006). Multi-biomaterial for controlled release of active substances [Poster presentation]. European conference on Biomaterials, Nantes, France. |
Delporte, J.-P., Delattre, L., & Herné, P. (2006). Le point sur les medicaments generiques et sur la prescription sous denomination commune. Revue Médicale de Liège, 61 (5-6, May-Jun), 459-63. Peer reviewed |
Barillaro, V., Van Hees, T., Piel, G., Evrard, B., & Delattre, L. (2006). Application of supercritical carbon dioxide to the preparation of inclusion complexes into cyclodextrins [Paper presentation]. 13th International Pharmaceutical Technology Symposium, Antalya, Turkey. |
Kirschvink, N, Leemans, J., Delvaux, F., Snaps, F., Jaspart, S., Evrard, B., Delattre, L., Cambier, C., Clercx, C., & Gustin, P. (2006). Inhaled fluticasone reduces bronchial responsiveness and airway inflammation in cats with mild chronic bronchitis. Journal of Feline Medicine and Surgery, 8 (1), 45-54. doi:10.1016/j.jfms.2005.07.001 Peer Reviewed verified by ORBi |
Stassen, T., Piette, M., Kinget, R., & Delattre, L. (2006). Etude des performances d'appareils de melange Unguator pour la preparation magistrale a usage dermatologique. Journal de Pharmacie de Belgique, 61 (1), 1-10. Peer Reviewed verified by ORBi |
Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (2006). Study of the interaction between cyclodextrins and liposomes membranes: effect on the permeability of liposomes [Paper presentation]. XIII th International Cyclodextrin Symposium, Torino, Italy. |
Tursilli, R., Scalia, S., Piel, G., Jaspart, S., & Delattre, L. (2006). Encapsulation of the sunscreen agent, octyl dimethyl PABA, in lipid microparticles: effect on photostability [Poster presentation]. Skin and Formulation, 2nd Symposium, Versailles, France. |
Patel, J., Belhadj Salem, Martin, G. P., Delattre, L., Evrard, B., Forbes, B., & Bosquillon, C. (2006). Use of the MTT assay to evaluate the biocompatibility of beta-cyclodextrin derivatives with respiratory epithelial cells. Journal of Pharmacy and Pharmacology, 58 (58), 64-65. Peer Reviewed verified by ORBi |
Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (November 2005). Effect of cyclodextrins on the membrane permeability of liposomes [Poster presentation]. 2nd EUFEPS conference on optimising drug delivery and formulation, Versailles, France. |
Barillaro, V., Bertholet, P., Evrard, B., Delattre, L., Dive, G., & Piel, G. (September 2005). Inclusion of miconazole into cyclodextrins by means of supercritical carbon dioxide: effect of acidic ternary compound and molecular modelling study [Poster presentation]. 15th International Symposium on Microencapsulation, Parma, Italy. |
Piel, G., Piette, M., Castagne, D., Barillaro, V., Evrard, B., & Delattre, L. (September 2005). Encapsulation of betamethasone-cyclodextrin inclusion complexes in liposmes: effect of cyclodextrins on the encapsulation efficinecy and the kinetic release of betamethasone [Poster presentation]. 15th International Symposium on Microencapsulation, Parma, Italy. |
bodson, C., Hubert, P., & Delattre, L. (12 June 2005). instrumentation of a high shear mixer for in-line monitoring of a pharmaceutical blending process using FT-NIR spectroscopy [Paper presentation]. PharmSciFair, Nice, France. |
Bertholet, P., Jaspart, S., Bodson, C., Piette, M., Piel, G., Delattre, L., & Evrard, B. (June 2005). The effect of cyclodextrins on the aqueous solubility of a new MMP inhihbitor: phase solubility, 1H-NMR spectroscopy and molecular modelling studies, preparation and stability study of nebulizable solutions [Poster presentation]. 1st Pharmaceutical Sciences Fair and Exhibition (PharmSciFair), Nice, France. |
Piel, G., Boulmedarat, L., Bochot, A., Lesieur, S., Delattre, L., & Fattal, E. (June 2005). Cyclodextrin-mediated drug release from liposomes dispersed within a bioadhesive gel. Pharmaceutical Research, 22 (6), 962-971. doi:10.1007/s11095-005-4591-2 Peer Reviewed verified by ORBi |
Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (June 2005). Pharmacokinetic study of a new syntheyic MMP inhibitor (Ro 28-2653) after IV and oral administration of solutions containing hydroxypropyl-b-cyclodextrin [Poster presentation]. 1st Pharmaceutical Sciences Fair and Exhibition (PharmSciFair), Nice, France. |
bodson, C., Hubert, P., & Delattre, L. (20 May 2005). instrumentation of a high shear mixer for in-line monitoring of a pharmaceutical blending process using FT-NIR spectroscopy. |
Chiap, P., Piette, M., Evrard, B., Frankenne, F., Christiaens, B., Piel, G., Cataldo, D., Foidart, J.-M., Delattre, L., Crommen, J., & Hubert, P. (05 March 2005). Automated method for the determination of a new matrix metalloproteinase inhibitor in ovine plasma and serum by coupling of restricted access material for on-line sample clean-up to liquid chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 817 (1), 109-117. doi:10.1016/j.jchromb.2004.08.042 Peer Reviewed verified by ORBi |
Piel, G., Piette, M., Castagne, D., Barillaro, V., Evrard, B., & Delattre, L. (March 2005). Influence des cyclodextrines sur la vitesse de libération de la bétamethasone encapsulée sous forme de complexe dans des liposomes [Paper presentation]. 8èmes Journées du Club français des Cyclodextrines, Nancy, France. |
Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (March 2005). Etude pharmacocinétique d'un nouvel inhibiteur des MMPs (I-col 51) après administration orale et intraveineuse de soultions à base d'hydroxypropyl-b-cyclodextrine [Paper presentation]. 8èmes Journées du Club français des Cyclodextrines, Nancy, France. |
Bertholet, P., Guéders, M., Dive, G., Albert, A., Barillaro, V., Perly, B., Cataldo, D., Piel, G., Delattre, L., & Evrard, B. (2005). The Effect of Cyclodextrins on the Aqueous Solubility of a New Mmp Inhibitor: Phase Solubility, 1 H-Nmr Spectroscopy and Molecular Modeling Studies, Preparation and Stability Study of Nebulizable Solutions. Journal of Pharmacy and Pharmaceutical Sciences, 8 (2), 164-175. Peer Reviewed verified by ORBi |
Jaspart, S., Piel, G., Delattre, L., & Evrard, B. (January 2005). Solid Lipid Microparticles: Formulation, Preparation, Characterisation, Drug Release and Applications. Expert Opinion on Drug Delivery, 2 (1), 75-87. doi:10.1517/17425247.2.1.75 Peer Reviewed verified by ORBi |
Barillaro, V., Evrard, B., Delattre, L., & Piel, G. (2005). Oral bioavailability in pigs of a miconazole/hydroxypropyl-gamma-cyclodextrin/L-tartaric acid inclusion complex produced by supercritical carbon dioxide processing. AAPS Journal, 7 (1), 149-E155. doi:10.1208/aapsj070116 Peer Reviewed verified by ORBi |
Guéders, M., Bertholet, P., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., Cataldo, D., & Evrard, B. (2005). Evaluation of the pulmonary inflammation and bronchial hyperresponsiveness in healthy mice induced by inhaled cyclodextrins. In Journal of inclusion Phenomena and Macrocyclic Chesmistry. Peer reviewed |
Jaspart, S., Bodson, C., Bertholet, P., Delattre, L., & Evrard, B. (2005). In vitro release of salbutamol acetonide from solid lipid nanoparticles. In Proceedings of 1st Pharmaceutical Sciences Fair and Exhibition. Peer reviewed |
Jaspart, S., Bertholet, P., Delattre, L., & Evrard, B. (2005). Study of solid lipid micriparticles as sustained release delivery system for pulmonary administration [Paper presentation]. 15th International symposium on microencapsulation, Parma, Italy. |
Barillaro, V., Bertholet, P., Henry de Hassonville, S., Ziemons, E., Evrard, B., Delattre, L., & Piel, G. (30 November 2004). Effect of acidic ternary compounds on the formation of miconazole/cyclodextrin inclusion complexes by means of supercritical carbon dioxide. Journal of Pharmacy and Pharmaceutical Sciences, 7 (3), 378-388. Peer Reviewed verified by ORBi |
Henry de Hassonville, S., Chiap, P., Liégeois, J.-F., Evrard, B., Delattre, L., Crommen, J., Piel, G., & Hubert, P. (21 September 2004). Development and validation of a high-performance liquid chromatographic method for the determination of cyproterone acetate in human skin. Journal of Pharmaceutical and Biomedical Analysis, 36 (1), 133-143. doi:10.1016/j.jpba.2004.05.023 Peer Reviewed verified by ORBi |
Roland, I., de Leval, X., Evrard, B., Pirotte, B., Dogné, J.-M., & Delattre, L. (August 2004). Modulation of the arachidonic cascade with omega 3 fatty acids or analogues: Potential therapeutic benefits. Mini Reviews in Medicinal Chemistry, 4 (6), 659-668. doi:10.2174/1389557043403738 Peer Reviewed verified by ORBi |
Piel, G., Boulmedarat, L., Bochot, A., Delattre, L., & Fattal, E. (May 2004). Influence of methyl-b-cyclodextrin on the relase kinetics of inulin encapsulated in bioadhesive liposomes [Poster presentation]. XII th International Cyclodextrin Symposium, Montpellier, France. |
Henry de Hassonville, S., Christiaens, B., Piel, G., Barillaro, V., Bertholet, P., Chiap, P., Hubert, P., Crommen, J., Delattre, L., Pierard, G., & Evrard, B. (May 2004). Effect of methylated-b-cyclodextrin on the skin and influence on cyproterone acetate percutaneous absorption [Poster presentation]. XII th International Cyclodextrin Symposium, Montpellier, France. |
Guéders, M., Bertholet, P., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., Cataldo, D., & Evrard, B. (May 2004). Evaluation of the pulmonary inflammation and the bronchial hyperresponsiveness in healthy mice induced by inhaled cyclodextrins [Paper presentation]. XII th International Cyclodextrin Symposium, Montpellier, France. |
Jaspart, S., Kirschvink, N., Chiap, P., Delattre, L., Crommen, J., Gustin, P., & Evrard, B. (2004). Solid lipid Nanoparticles for administration by inhalation : Optimisation of manufacturing parameters and preliminary tolerance study [Paper presentation]. 12eme Forum des Sciences Pharmaceutiques, Blankenberge, Belgium. |
Piel, G., Moutard, S., Perly, B., Henry de Hassonville, S., Bertholet, P., Barillaro, V., Piette, M., Delattre, L., & Evrard, B. (2004). Comparison of two methods currently used to determine the interaction between cyclodextrins and drugs: phase solubility diagrams and NMR spectroscopy. Journal of Drug Delivery Science and Technology, 14 (1, JAN-FEB), 87-91. doi:10.1016/s1773-2247(04)50010-2 Peer reviewed |
Henry de Hassonville, S., Dive, G., Evrard, B., Barillaro, V., Bertholet, P., Delattre, L., & Piel, G. (2004). Application of molecular modeling to the study of cyproterone acetate stability in the presence of cyclodextrin derivatives. Journal of Drug Delivery Science and Technology, 14 (5, SEP-OCT), 357-362. doi:10.1016/s1773-2247(04)50064-3 Peer reviewed |
Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (2004). Skin compatibility of cyclodextrins and their derivatives: a comparative assessment using a corneoxenometry bioassay. European Journal of Pharmaceutics and Biopharmaceutics, 57 (3), 479-82. doi:10.1016/j.ejpb.2003.12.004 Peer Reviewed verified by ORBi |
Piel, G., Boulmedarat, L., Bochot, A., Evrard, B., Delattre, L., & Fattal, E. (January 2004). Etude des interactions cyclodextrines-liposomes: modification de la cinétique de libération de l'inuline encapsulée dans des lioposomes bioadhésifs en présence de méthyl-b-cyclodextrine [Paper presentation]. 7èmes Journées du Club français des Cyclodextrines, Lille, France. |
Sanna, V., Kirschvink, N., Gustin, P., Gavini, E., Roland, I., Delattre, L., & Evrard, B. (2004). Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS PharmSci, 5 (2), 27. doi:10.1208/pt050227 Peer Reviewed verified by ORBi |
Evrard, B., Hubert, P., Delvenne, P., Boniver, J., & Delattre, L. (2004). Development of a hydrogel containing GM-CSF to improve the dendritic cells colonisation of HPV+ epithelium. In Proceedings of Eur conference on drug delivery and pharmaceutical technology. Peer reviewed |
Evrard, B., Bertholet, P., Guéders, M., Flament, M. P., Piel, G., Delattre, L., Gayot, A., Leterme, P., Foidart, J.-M., & Cataldo, D. (2004). Cyclodextrins as a potential carrier in drug nebulization. Journal of Controlled Release, 96 (3), 403-410. doi:10.1016/j.jconrel.2004.02.010 Peer Reviewed verified by ORBi |
Henry de Hassonville, S., Christiaens, B., Piel, G., Barillaro, V., Bertholet, P., Chiap, P., Hubert, P., Crommen, J., Delattre, L., Pierard, G., & Evrard, B. (2004). La Rameb, un promoteur d’absorption cutanée pour l’acétate de cypro-térone ? [Paper presentation]. 7e journées du club cyclodextrines, Lille, France. |
Jaspart, S., Bodson, C., Bertholet, P., Chiap, P., Delattre, L., & Evrard, B. (2004). Solid lipid Nanoparticles for administration by inhalation : Optimisation of manufacturing parameters [Paper presentation]. European Conference on Drug Delivery and Pharmaceutical Technology, Sevilla, Spain. |
Roland, I., Gillard, P., Delattre, L., Evrard, B., & de LA BRASSINNE, M. (2004). Characterisation of a novel topical nanoemulsion vehicle with spreading properties. In Proceedings of Eur conference on drug delivery and pharmaceutical technology. Peer reviewed |
Hubert, P., Evrard, B., Maillard, C., Franzen-Detrooz, E., Delattre, L., Foidart, J.-M., Noël, A., Boniver, J., & Delvenne, P. (2004). Delivery of granulocyte-macrophage colony-stimulating factor in bioadhesive hydrogel stimulates migration of dendritic cells in models human papillomavirus-associated (pre)neoplastic epithelial lesions. Antimicrobial Agents and Chemotherapy, 48 (11), 4342-4348. doi:10.1128/AAC.48.11.4342-4348.2004 Peer Reviewed verified by ORBi |
Piel, G., Boulmedarat, L., Bochot, A., Evrard, B., Delattre, L., & Fattal, E. (12 November 2003). Influence de la methyl-b-cyclodextrine sur la cinetique de libération de l'inuline encapsulée dans des liposomes bioadhésifs [Poster presentation]. 18ème Journée Scientifique du GTRV, Lille, France. |
Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (October 2003). The skin compatibility of new cyclodextrin derivatives: the phospholipidyl-cyclodextrins [Poster presentation]. Skin and Formulation, 1st Symposium, Paris, France. |
Roland, I., Piel, G., Delattre, L., & Evrard, B. (16 September 2003). Systematic characterization of oil-in-water emulsions for formulation design. International Journal of Pharmaceutics, 263 (1-2), 85-94. doi:10.1016/S0378-5173(03)00364-8 Peer Reviewed verified by ORBi |
Delattre, L., Henry de Hassonville, S., & Evrard, B. (04 June 2003). Hydrosoluble mixtures of cyproterone and/or an ester of it, processes to obtain them and uses thereof. |
Bertolla, C., Piette, M., Evrard, B., Delattre, L., Piel, G., Frédérick, R., & Masereel, B. (May 2003). Synthèse de b-cyclodextrines modifiées [Poster presentation]. 17th Journées Franco-belges de Pharmacochimie, Bruxelles, Belgium. |
Roland, I., Piel, G., Delattre, L., & Evrard, B. (May 2003). Systematic characterization of oil-in-water emulsion for formulation design [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
Bertholet, P., Cataldo, D., Guéders, M., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., & Evrard, B. (May 2003). Effect of inhaled cyclodextrins on the pulmonary inflammation and bronchial hyperresponsiveness in mice [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
Henry de Hassonville, S., Dive, G., Prosperi, C., Perly, B., Piel, G., Barillaro, V., Bertholet, P., Delattre, L., Llabres, G., & Evrard, B. (May 2003). Influence of cyclodextrins on the solubility and the stability of cyproterone acetate [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (May 2003). An ex-vivo study of the skin compatibility of new cyclodextrin derivatives: the phospholipidyl-cyclodextrins [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
Henry de Hassonville, S., Christiaens, B., Piel, G., Barillaro, V., Bertholet, P., Chiap, P., Hubert, P., Crommen, J., Delattre, L., Pierard, G., & Evrard, B. (2003). Cyclodextrins as topical permeation enhancers : in vitro and in vivo testing [Poster presentation]. Symposium skin and formulation APGI, Paris, France. |
Roland, I, Evrard, B., Erpicum, T, & Delattre, L. (2003). Formulation of submicronic emulsions by using a high-pressure homogeniser. Journal de Pharmacie de Belgique, 57, 68-70. Peer Reviewed verified by ORBi |
Barillaro, V., Van Hees, T., Bertini, S., Piel, G., Bertholet, P., Henry de Hassonville, S., Evrard, B., & Delattre, L. (January 2003). Etude de l'inclusion du miconazole dans les cyclodextrines par le CO2 supercritique: caracterisation des complexes par HPLC, CP-MAS-NMR et FT-IR [Paper presentation]. 6èmes Journées du Club français des Cyclodextrines, Montpellier, France. |
Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (January 2003). Etude comparative de la tolérance cutanée de nouveaux dérivés amphiphiles de cyclodextrines: les phospholipidyl-cyclodextines [Paper presentation]. 6èmes Journées du Club français des Cyclodextrines, Montpellier, France. |
Sanna, V., Kirschvink, N., Gustin, P., Gavini, E., Roland, I., Delattre, L., & Evrard, B. (2003). Solid lipid Nanoparticles for drug Pumonary Administration. In Proceedings of 30th International Symposium on Controlled Release of Bioactive Materials. Peer reviewed |
Bertholet, P., Guéders, M., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., Cataldo, D., & Evrard, B. (January 2003). Etude de l'hyperactivité bronchique induite par l'administration pulmonaire de cyclodextrines chez la souris [Paper presentation]. 6èmes Journées du Club français des Cyclodextrines, Montpellier, France. |
Roland, I., Gillard, P., Delattre, L., Evrard, B., & de LA BRASSINNE, M. (2003). Formulation and evaluation of a novel topical nanoemulsion vehicle with spreading properties [Poster presentation]. Symposium Skin and formulation, Paris, France. |
Evrard, B., Chiap, P., De Tullio, P., Ghalmi, F., Piel, G., Van Hees, T., Crommen, J., Losson, B., & Delattre, L. (13 December 2002). Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin. Journal of Controlled Release, 85 (1-3), 45-50. doi:10.1016/S0168-3659(02)00270-5 Peer Reviewed verified by ORBi |
Van Hees, T., Barillaro, V., Piel, G., Bertholet, P., De Hassonville, S., Evrard, B., & Delattre, L. (December 2002). Application of Supercritical carbon dioxide for the preparation of drug-cyclodextrin inclusion compounds. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 44 (1-4), 271-274. doi:10.1023/A:1023084617964 Peer reviewed |
Van Hees, T., Piel, G., Henry de Hassonville, S., Evrard, B., & Delattre, L. (May 2002). Determination of the free/included piroxicam ratio in cyclodextrin complexes: comparison between UV spectrophotometry and differential scanning calorimetry. European Journal of Pharmaceutical Sciences, 15 (4), 347-353. doi:10.1016/S0928-0987(02)00018-0 Peer Reviewed verified by ORBi |
Piel, G., Moutard, S., Van Hees, T., Henry de Hassonville, S., Delattre, L., & Evrard, B. (April 2002). Determination of the interaction between cyclodextins and drugs: comparison of two methods (phase solubility diagrams and NMR) [Poster presentation]. 4th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Firenze, Italy. |
Henry de Hassonville, S., Perly, B., Piel, G., Van Hees, T., Barillaro, V., Betholet, P., Evrard, B., & Delattre, L. (February 2002). Augmentation de la solubilité de l'acétate de cyprotérone par formation de complexes d'inclusion dans les cyclodextrines [Paper presentation]. 5èmes Journées du Club français des Cyclodextrines, Amiens, France. |
Barillaro, V., Van Hees, T., Piel, G., Henry de Hassonville, S., Bertholet, P., Evrard, B., & Delattre, L. (February 2002). Influence de l'ajout d'un composé ternaire dans la formation d'un complexe d'inclusion de miconazole dans les cyclodextrines par CO2 supercritique [Paper presentation]. 5ème Journée du Club français des Cyclodextrines, Amiens, France. |
Henry de Hassonville, S., Perly, B., Piel, G., Van Hees, T., Delattre, L., & Evrard, B. (2002). Inclusion Complexes of Cyproterone Acetate with Cyclodextrins in Aqueous Solution. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 44, 289-292. doi:10.1023/A:1023099611604 Peer reviewed |
Otte, X, Evrard, B., Delattre, L., & Thunus, L. (2002). Development and validation of a new Fourier transform infrared spectrometric method for the quantification of urea in creams and ointments. Analytica Chimica Acta, 451, 323-328. doi:10.1016/S0003-2670(01)01416-7 Peer Reviewed verified by ORBi |
Piel, G., Hayette, M.-P., Pavoni, E., Evrard, B., Van Hees, T., Henry de Hassonville, S., De Mol, P., & Delattre, L. (July 2001). In Vitro Comparison of the Antimycotic Activity of a Miconazole-Hp-Beta-Cyclodextrin Solution with a Miconazole Surfactant Solution. Journal of Antimicrobial Chemotherapy, 48 (1), 83-7. doi:10.1093/jac/48.1.83 Peer Reviewed verified by ORBi |
Piel, G., Dive, G., Evrard, B., Van Hees, T., Henry de Hassonville, S., & Delattre, L. (June 2001). Molecular Modeling Study of Beta- and Gamma-Cyclodextrin Complexes with Miconazole. European Journal of Pharmaceutical Sciences, 13 (3), 271-9. doi:10.1016/S0928-0987(01)00113-0 Peer Reviewed verified by ORBi |
Roland, I., Evrard, B., Erpicum, T., & Delattre, L. (2001). Formulation of subcronic emulsions by using a high-pressure homogeniser [Paper presentation]. 10th Forum of Pharmaceutical Sciences, Montreal, Canada. |
Roland, I., Evrard, B., Erpicum, T., & Delattre, L. (2001). Formulation and characterisation of submicronic emulsions [Paper presentation]. International Symposium on Material Characterisation an Technology, Bruxelles, Belgium. |
Piel, G., Llabres, G., Evrard, B., Van Hees, T., Henry de Hassonville, S., & Delattre, L. (2001). A nuclear magnetic resonance study of the miconazole-b-cyclodextrin inclusion complex in an acidic medium: determination of the structure and stability constants. STP Pharma Sciences, 11 (3), 235-238. Peer reviewed |
Gautier, S., Grudzielski, N., Goffinet, G., Henry de Hassonville, S., Delattre, L., & Jérôme, R. (2001). Preparation of poly(D,L-lactide) nanoparticles assisted by amphiphilic poly(methyl methacrylate-co-methacrylic acid) copolymers. Journal of Biomaterials Science. Polymer Edition, 12 (4), 429-450. doi:10.1163/156856201750195306 Peer Reviewed verified by ORBi |
Alvarez, C, Van Hees, T., Piel, G., Liégeois, J.-F., Evrard, B., Torrado, J.J, & Delattre, L. (2001). Préparation de complexes mebendazole-HPβCD à l'aide de polymères solubles dans l'eau et d'acides organiques. Annales Pharmaceutiques Françaises, 59, 380. Peer Reviewed verified by ORBi |
Alvarez, C., Van Hees, T., Piel, G., Liégeois, J.-F., Delattre, L., & Evrard, B. (2001). Preparation of mebendazole HP-beta-cyclodextrin complexes using water-soluble polymers and organic acids. STP Pharma Sciences, 11 (6), 439-442. Peer reviewed |
Piel, G., Pavoni, E., Evrard, B., Van Hees, T., Henry de Hassonville, S., & Delattre, L. (December 2000). Etude comparative de l'effet de différents acides et de différentes cyclodextrines sur la solubilité du miconazole, du kétoconazole et de l'itraconazole [Paper presentation]. 4ème Journée du Club français des Cyclodextrines, Grenoble, France. |
Van Hees, T., Piel, G., Evrard, B., Henry de Hassonville, S., & Delattre, L. (December 2000). Solubility of p-hydroxybenzoic esters in supercritical carbon dioxide [Poster presentation]. 7th Meeting on Supercritical Fluids, Antibes, France. |
Alvarez, C., Van Hees, T., Piel, G., Liégeois, J.-F., Evrard, B., Torrado, J., & Delattre, L. (December 2000). Préparation de complexes mébendazole-HPbCD à l'aide de polymères solubles dans l'eau et d'acides organiques [Paper presentation]. 4ème Journée du Club français des Cyclodextrines, Grenoble, France. |
Piel, G., Evrard, B., Van Hees, T., Pierard, G., de LA BRASSINNE, M., & Delattre, L. (May 2000). Development of a cutaneous hydrogel containing miconazole by the useof hydroxypropyl-b-cyclodextrin and lactic acid [Poster presentation]. Xth International Cyclodextrin Symposium, Michigan, United States. |
Piel, G., Evrard, B., Van Hees, T., Hayette, M.-P., De Mol, P., & Delattre, L. (May 2000). Development of a new parenteral solution of miconazole by the use of cyclodextrins derivatives [Poster presentation]. Xth International Cyclodextrin Symposium, Michigan, United States. |
Piel, G., Evrard, B., Van Hees, T., Pierard, G., de LA BRASSINNE, M., & Delattre, L. (April 2000). Development of a cutaneous hydrogel containing miconazole hydroxypropyl-b-cyclodextrin and lactic acid: study of its tolerability and efficacy [Paper presentation]. IXth Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
Alvarez, C., Van Hees, T., Piel, G., Liégeois, J.-F., Evrard, B., Torrado, J., & Delattre, L. (April 2000). Preparation of mebendazole HP-b-cyclodextrin complexes using water soluble polymers and organic acids [Paper presentation]. IXth Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
Chiap, P., Evrard, B., Bimazubute, M. A., De Tullio, P., Hubert, P., Delattre, L., & Crommen, J. (10 February 2000). Determination of Albendazole and Its Main Metabolites in Ovine Plasma by Liquid Chromatography with Dialysis as an Integrated Sample Preparation Technique. Journal of Chromatography. A, 870 (1-2), 121-34. doi:10.1016/S0021-9673(99)00938-3 Peer Reviewed verified by ORBi |
Van Hees, T., Evrard, B., Piel, G., & Delattre, L. (2000). Inclusion of Piroxicam into Beta-Cyclodextrin by Means of Supercritical Carbon Dioxide: Thermal, Spectroscopic and Physicochemical Studies. Journal de Pharmacie de Belgique, 55 (1, Jan-Feb), 30-1. |
Van Hees, T., Piel, G., Evrard, B., Otte, X., Thunus, L., & Delattre, L. (December 1999). Application of Supercritical Carbon Dioxide for the Preparation of a Piroxicam-Beta-Cyclodextrin Inclusion Compound. Pharmaceutical Research, 16 (12), 1864-70. doi:10.1023/A:1018955410414 Peer Reviewed verified by ORBi |
Evrard, B., Amighi, K., Beten, D., Delattre, L., & Moes, A. J. (November 1999). Influence of Melting and Rheological Properties of Fatty Binders on the Melt Granulation Process in a High-Shear Mixer. Drug Development and Industrial Pharmacy, 25 (11), 1177-84. doi:10.1081/DDC-100102285 Peer Reviewed verified by ORBi |
Evrard, B., & Delattre, L. (06 October 1999). SUSTAINED RELEASE PHARMACEUTICAL TABLETS WITH TRAMADOL BASE AND THEIR PREPARATION. |
Van Hees, T., Evrard, B., Piel, G., & Delattre, L. (May 1999). Inclusion of piroxicam into b-cyclodextrin by means of supercritical carbon dioxide: thermal, spectroscopic and physicochemical studies [Paper presentation]. VIIIth Forum of Pharmaceutical Sciences. |
Piel, G., Hayette, M.-P., Evrard, B., Van Hees, T., De Mol, P., & Delattre, L. (May 1999). A comparative study of the antimycotic activity of a miconazole-HP-b-CD solution to a surfactant solution [Paper presentation]. VIIIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
Piel, G., Evrard, B., Van Hees, T., & Delattre, L. (25 March 1999). Comparison of the Iv Pharmacokinetics in Sheep of Miconazole-Cyclodextrin Solutions and a Micellar Solution. International Journal of Pharmaceutics, 180 (1), 41-5. doi:10.1016/S0378-5173(98)00403-7 Peer Reviewed verified by ORBi |
Chiap, P., Hubert, P., Bimazubute, M., Evrard, B., Delattre, L., & Crommen, J. (1999). LC determination of albendazole and its main metabolites in ovine plasma using dialysis as integrated sample preparation technique [Poster presentation]. XXIIIrd International Symposium on High Performance Liquid Phase Separations and Related Techniques, Grenade, Spain. |
Evrard, B., De Tullio, P., Chiap, P., Van Hees, T., Piel, G., Crommen, J., Losson, B., & Delattre, L. (1999). The effect of hydroxypropyl-b-cyclodextrins on the pharamacokinetics of albendazole in sheep. In Proceedings of 26th International Symposium on Controlled Release of Bioactive Materials. Peer reviewed |
Chiap, P., Evrard, B., Bimazubute, M., De Tullio, P., Hubert, P., Delattre, L., & Crommen, J. (1999). On-line combinaison of dialysis with liquid chromatography for the automated determination of albendazole and its main metabolites in ovine plasma [Paper presentation]. VIIIème Forum des Sciences Pharmaceutiques, Spa, Belgium. |
Piel, G., Evrard, B., Van Hees, T., Llabres, G., & Delattre, L. (1999). Development of a parenteral and of an oral formulation of albendazole with cyclodextrins. STP Pharma Sciences, 3, 257-260. Peer reviewed |
Piel, G., Hayette, M.-P., Evrard, B., Van Hees, T., De Mol, P., & Delattre, L. (1999). A Comparative Study of the Antimycotic Activity of a Miconazole Hp-Beta Cyclodextrin Solution and a Surfactant Solution. Journal de Pharmacie de Belgique, 54 (3, May-Jun), 87-8. |
Chiap, P., Planck, I., Evrard, B., Hubert, P., Delattre, L., & Crommen, J. (1998). Automated determination of acyclovir in human plasma using solid phase extraction and liquid chromatography. Journal de Pharmacie de Belgique, 53, 172. Peer Reviewed verified by ORBi |
Evrard, B., Chiap, P., Piel, G., Van Hees, T., Ghalmi, F., Losson, B., & Delattre, L. (1998). Influence of cyclodextrins on the solubility and the pharmacokinetics of albendazole [Poster presentation]. IXth International Cyclodextrin Symposium, Santiago de Compostela, Spain. |
Piel, G., Evrard, B., Van Hees, T., Fernandez del Pozo, C., & Delattre, L. (1998). Development of a sustained release dosage form diclofenac-cyclodextrin inclusion complex [Poster presentation]. IX th International Cyclodextrin Symposium, Santiago de Compostela, Spain. |
Piel, G., Evrard, B., Fillet, M., Llabres, G., & Delattre, L. (1998). Development of a non-surfactant parenteral formulation of miconazole by the use of cyclodextrins. International Journal of Pharmaceutics, 169, 15-22. doi:10.1016/S0378-5173(98)00103-3 Peer Reviewed verified by ORBi |
Evrard, B., Piel, G., Van Hees, T., Ghalmi, F., Losson, B., & Delattre, L. (1998). Development and pharmacokinetic evaluation of an oral liquid formulation of albendazole with cyclodextrins [Poster presentation]. 2th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Paris, France. |
Piel, G., Van Hees, T., Evrard, B., & Delattre, L. (1998). A comparative pharmacokinetic study of intravenous solutions containig miconazole with or without cyclodextrins [Poster presentation]. IXth International Cyclodextrin Symposium, Santiago de Compostela, Spain. |
Piel, G., Llabres, G., Fillet, M., Evrard, B., Van Hees, T., & Delattre, L. (1998). A proton nuclear resonance study of the inclusion complex of miconazole with b-cyclodextrin in an acidic medium [Poster presentation]. 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Paris, France. |
Van Hees, T., Evrard, B., Piel, G., & Delattre, L. (1998). A comparative study of the dissolution properties of piroxicam-b-cyclodextrin inclusion complexes prepared by different methods [Poster presentation]. IXth International Cyclodextrin Symposium, Santiago de Compostela, Spain. |
Van Hees, T., Piel, G., Evrard, B., & Delattre, L. (1998). Preparation of a drug-b-cyclodextrin inclusion compound using supercritical carbon dioxide [Poster presentation]. 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Paris, France. |
Piel, G., Evrard, B., & Delattre, L. (July 1997). Study of the combined effects of cyclodextrins and buffer type on the solubility of miconazole [Poster presentation]. Pharmaceutical applications of cyclodextrins conference, Lawrence, Kansas, United States. |
Evrard, B., Piel, G., Ceccato, A., & Delattre, L. (July 1997). Effects of cyclodextrins on the solubility characteristics of albendazole [Poster presentation]. Pharmaceutical appplication of Cyclodextrins Conference, Lawrence, Kansas, United States. |
Piel, G., Fillet, M., Evrard, B., Crommen, J., & Delattre, L. (July 1997). Comparison of the binding constant values of complexes of different antimycotic imidazole derivatives with cyclodextrin obtained by capillary electrophoresis and phase solubility diagram [Poster presentation]. Pharmaceutical applications of cyclodextrins conference, Lawrence, Kansas, United States. |
Evrard, B., Ceccato, A., Gaspard, O., Delattre, L., & Delporte, J.-P. (01 May 1997). Stability of Ondansetron Hydrochloride and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Injection and in 5% Dextrose Injection. American Journal of Health-system Pharmacy, 54 (9), 1065-8. doi:10.1093/ajhp/54.9.1065 Peer Reviewed verified by ORBi |
Piel, G., Pirotte, B., Delneuville, I., Neven, P., Llabres, G., Delarge, J., & Delattre, L. (April 1997). Study of the Influence of Both Cyclodextrins and L-Lysine on the Aqueous Solubility of Nimesulide; Isolation and Characterization of Nimesulide-L-Lysine-Cyclodextrin Complexes. Journal of Pharmaceutical Sciences, 86 (4), 475-80. doi:10.1021/js960298k Peer Reviewed verified by ORBi |
Piel, G., Evrard, B., & Delattre, L. (April 1997). Multicomponent complexes of miconazole with different acids and cyclodextrins [Paper presentation]. VIIth Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
Duvivier, F., Grandfils, C., Léonard, F., Evrard, B., & Delattre, L. (1997). The size of nanoparticles after their incorporation in gastroresistant spheroids. Journal de Pharmacie de Belgique, 52 (3), 123. Peer Reviewed verified by ORBi |
Duvivier, F., Grandfils, C., Léonard, F., Evrard, B., & Delattre, L. (1997). Development of a nanoparticular oral delivery system : study of the size of the nanoparticles after incorporation into gastroresistant pellets [Paper presentation]. 7th Forum of Pharmaceutical Sciences. |
Piel, G., Evrard, B., & Delattre, L. (1997). Complexes à multicomposants de miconazole avec différents acides et cyclodextrines. Journal de Pharmacie de Belgique, 52 (3), 124. |
Duvivier, F, Grandfils, C., Léonard, F, Evrard, B., & Delattre, L. (1997). Etude de la taille des nanoparticules après incorporation dans des sphéroïdes gastrorésistants. Journal de Pharmacie de Belgique, 52 (3), 123. Peer Reviewed verified by ORBi |
Duvivier, F., Lübbering, B., Léonard, F., Evrard, B., Goffinet, G., & Delattre, L. (1997). Influence of the amount of enteric polymer on the disintegration rate of pellets designed for protein delivery : in vitro and in vivo tests. In Proceedings of Symposium on Particulate Systems, From Formulation to Prduction. Peer reviewed |
Piel, G., Pochet, L., Delattre, L., & Delarge, J. (April 1996). Study of the influence of g-cyclodextrin on the molsidomine photostability [Poster presentation]. VIIIth International Cyclodextrin Symposium, Budapest, Hungary. |
Piel, G., Delneuville, I., & Delattre, L. (April 1996). In vitro and in vivo studies on sodium nimesulide-b-cyclodextrin inclusion complexes [Poster presentation]. VIIIth International Cyclodextrin Symposium, Budapest, Hungary. |
Piel, G., Pirotte, B., Delneuville, I., Neven, P., Delarge, J., & Delattre, L. (February 1996). Preparation by spray drying of b and g-cyclodextrin inclusion complexes of a poorly soluble non steroidal anti-inflammatory drug [Poster presentation]. Formulation of Poorly-Available Drugs for Oral Administration, European Symposium, Paris, France. |
Piel, G., Pirotte, B., Delneuville, I., Neven, P., Delarge, J., & Delattre, L. (1996). Nimesulide-L-lysine-β- and γ-cyclodextrin complexes: preparation and dissolution properties. Journal de Pharmacie de Belgique, 51, 117. Peer Reviewed verified by ORBi |
Evrard, B., Ceccato, A., Colson, A., Léonard, F., Gaspard, O., Delporte, J.-P., & Delattre, L. (1996). Stability of ondansetron hydrochloride and dexamethazone sodium phosphate admixtures in injectable solutions [Paper presentation]. Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
Evrard, B., & Delattre, L. (1996). In vitro evaluation of lipid matrices for the development of a sustained-release sulfamethazine bolus for lambs. Drug Development and Industrial Pharmacy, 22 (2), 111-118. doi:10.3109/03639049609041980 Peer Reviewed verified by ORBi |
Evrard, B., & Delattre, L. (1996). Formes pharmaceutiques à libération prolongée en médecine vétérinaire : systèmes à rétention dans le réticulo-rumen = Sustained-released veterinary dosage forms : retention devices in the reticulorumen. STP Pharma Pratiques, 6 (6), 479-486. Peer reviewed |
Piel, G., Pochet, L., Delattre, L., & Delarge, J. (June 1995). Photostability studies of molsidomine-cyclodextrin complexes [Poster presentation]. Photostability of drugs, 1st International Meeting, Oslo, Norway. |
Evrard, B., Hubert, P., Chiap, P., Crommen, J., & Delattre, L. (1995). A fully automated HPLC method for pharmacokinetic studies on a long-acting sulfamethazine veterinary bolus. Journal de Pharmacie de Belgique, 50, 328. Peer Reviewed verified by ORBi |
Evrard, B., Hubert, P., Chiap, P., Crommen, J., & Delattre, L. (1995). A fully automated HPLC method for pharmacokinetic studies on a long-acting sulfamethazine veterinary bolus [Paper presentation]. 5th International Symposium on Drug Analysis, Leuven, Belgium. |
Evrard, B., Delahaut, P., Hubert, P., Crommen, J., & Delattre, L. (1995). Biopharmaceutical aspects of the development of a sulfamethazine oral sustained release bolus for lambs. Journal of Controlled Release, 35, 107-115. doi:10.1016/0168-3659(95)00025-4 Peer Reviewed verified by ORBi |
Evrard, B., & Delattre, L. (1995). Evaluation of the correlation between "in vitro" and "in vivo" release of sulfamethazine from a long-acting ovine bolus. In Proceedingsof 1st World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (pp. 927-928). Peer reviewed |
Evrard, B., Delahaut, P., & Delattre, L. (1994). Pharmacokinetic evaluation of a long-acting sulfamethazine bolus for lambs. In Proceedings of 21th International Symposium on controlled release of Bioactive Materials. Peer reviewed |
Hubert, P., Chiap, P., Evrard, B., Delattre, L., & Crommen, J. (08 December 1993). Fully Automated Determination of Sulfamethazine in Ovine Plasma Using Solid-Phase Extraction on Disposable Cartridges and Liquid Chromatography. Journal of Chromatography. A, 622 (1), 53-60. doi:10.1016/0378-4347(93)80249-4 Peer Reviewed verified by ORBi |
Evrard, B., Peerboom, C., & Delattre, L. (1993). Evaluation of a new laboratory high-shear mixer [Paper presentation]. Forum des Sciences Pharmaceutiques, Blankenberge, Belgium. |
Evrard, B., & Delattre, L. (1992). Development of a long acting sulfamethazine bolus for sheep [Paper presentation]. Second European Symposium on Controlled Drug Delivery, Noordwijk aan Zee, Netherlands. |
Evrard, B., Dechesne, J.-P., Fagetton, X., & Delattre, L. (1992). Development of a sustained release bolus for sheep : "in vitro" and "in vivo" results. In Proceedings of 19th International Symposium on controlled release of Bioactive Materials (pp. 435-436). Peer reviewed |
Evrard, B., Dechesne, J.-P., Fagetton, X., Zygraich, N., & Delattre, L. (1992). Development of a long-acting sulfamethazine bolus for sheep. In Proceedings of 6th International Conference of Pharmaceutical Technology (pp. 114-122). Peer reviewed |
Hubert, P., Evrard, B., Delattre, L., & Crommen, J. (1992). Automated determination of sulfadimidine in ovine plasma by solid phase extraction and HPLC. Journal de Pharmacie de Belgique, 47, 197. Peer Reviewed verified by ORBi |
Delneuville, I., Evrard, B., Kapusta, D., Dechesne, J.-P., & Delattre, L. (1992). Développement galénique d'une forme matricielle à libération prolongée renfermant un actif hydrosoluble. In Proceedings of 6th International Conference of Pharmaceutical Technology. Peer reviewed |
Evrard, B., & Delattre, L. (1992). Melt-Granulation with a new laboratory high-shear mixer. In Proceedings of 6th International Conference of Pharmaceutical Technology. Peer reviewed |
Evrard, B., Gougnard, T., & Delattre, L. (March 1991). Cystéamine therapy for children with nephropathic cystinosis : stability of cysteamine in eyedrops and drinkable solutions [Paper presentation]. Forum des Sciences Pharmaceutiques, Houffalize, Belgium. |
Evrard, B., Dechesne, J.-P., Fagetton, X., Zygraich, N., & Delattre, L. (March 1990). Development of a sustained release bolus for lambs [Paper presentation]. Forum des Sciences Pharmaceutiques, De Haan, Belgium. |
Bontemps, J., Pirson, P., Falmagne, J.-B., Jérôme, R., Theyssie, P., Delattre, L., & Evrard, B. (01 February 1989). MICROPARTICLES COMPRISING A BIODEGRADABLE POLYMER CONTROLLING THE RELEASE OF AN ANTIMALARIAL DRUG, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR THEIR PREPARATION. |
Evrard, B., Delattre, L., & Dechesne, J.-P. (1987). Stabilité des collyres à base de chlorhydrate de cystéine. Pharmakon, 69, 7-10. Peer reviewed |
Evrard, B., Dechesne, J.-P., & Delattre, L. (December 1986). Influence of propyleneglycol, dimethylisosorbide and isopropylmyristate on in vitro release of an antihistaminic drug from a transdermal therapeutic system [Poster presentation]. Neu-Ulm Conferance on transdermal Drug delivery, Neu Ulm, Germany. |
Delattre, L., & Evrard, B. (1985). Mise au point d'une formulation d'un gel topique à base de Dermovate lotion. Journal de Pharmacie de Belgique, 40 (5), 343-344. |